Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of salvianolic acid A and medicine composition thereof from Salia miliiorrhiza Bge.

A kind of technology of salvianolic acid and composition of salvia miltiorrhiza, applied in the field of traditional Chinese medicine

Inactive Publication Date: 2009-06-17
PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Salvianolic acid A [salvianolic acid A] is one of the active ingredients of Danshen. Phenolic acid A has a good therapeutic effect on cardiovascular and cerebrovascular diseases, but so far, there is no literature report that salvianolic acid A or containing salvianolic acid A has the effect of treating arrhythmia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of salvianolic acid A and medicine composition thereof from Salia miliiorrhiza Bge.
  • Use of salvianolic acid A and medicine composition thereof from Salia miliiorrhiza Bge.
  • Use of salvianolic acid A and medicine composition thereof from Salia miliiorrhiza Bge.

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Salvianolic acid A, used to treat arrhythmia.

Embodiment 2

[0061] Using salvianolic acid A as a raw material, according to the conventional requirements of pharmacy, it is prepared into a pharmaceutically acceptable pharmaceutical preparation for treating arrhythmia.

Embodiment 3

[0063] A prescription that uses salvianolic acid A as the monarch drug or ministerial drug, and the ingredients compatible with salvianolic acid A include ginseng, Ophiopogon japonicus, dogwood, jujube seed, mulberry, red peony root, ground beetle, Gansong, coptis, Schisandra, Longgu, Scutellaria, Radix Isatidis, Folium Isatidis, Codonopsis, Poria, Atractylodes macrocephala, Chuanqin, Astragalus, Baiziren, Double Flower, Bupleurum, Cundong, Panax notoginseng, Aconite, Guizhi, Asarum, Ephedra, Epimedium Huo, Licorice, Sophora flavescens, Hawthorn, Polygonatum and other active ingredients or one or more of the effective parts of traditional Chinese medicines to form a pharmaceutical composition for treating arrhythmia.

[0064] Alternatively, the above-mentioned pharmaceutical composition is used as a raw material to prepare a pharmaceutically acceptable pharmaceutical preparation according to the conventional requirements of pharmacy for treating arrhythmia.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses salvianolic acid A and a novel use of pharmaceutical composition comprising salvianolic acid A. The invention is characterized by the application of salvianolic acid A in preparing the medicament for treating arrhythmia, and the application of pharmaceutical composition composed of salvianolic acid A, ginseng, ophiopogon root, cornus officinalis, quinidine, lignocaine, etc. in preparing the medicament for treating arrhythmia. The pharmaceutical and clinical researches show that the salvianolic acid A and pharmaceutical composition comprising salvianolic acid A have excellent treating function for arrhythmia.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, and relates to a new medical application of salvianolic acid A and a pharmaceutical composition containing salvianolic acid A. [0002] The arrhythmia described in the present invention mainly refers to common heart arrhythmia in clinical hospitals. [0003] The arrhythmia mentioned in the present invention refers to any abnormality of heart rhythm origin, heart rate and rhythm, and impulse conduction. [0004] The arrhythmia mentioned in the present invention mainly refers to the abnormality of the frequency, rhythm, origin site, conduction velocity or excitation sequence of cardiac impulses. According to the principle of its occurrence, it can be divided into two categories: abnormal impulse formation and abnormal impulse conduction. Abnormal impulse formation: (1) sinus arrhythmia 1, sinus tachycardia; 2, sinus bradycardia; 3, sinus arrhythmia; 4, sinus arrest; (2) ectopic rhythm 1,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/216A61P9/06
Inventor 顾群栗艳彬鄯慧珍李志刚渠守峰
Owner PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com